307 related articles for article (PubMed ID: 21523369)
1. Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.
Schey R; Rao SS
Dig Dis Sci; 2011 Jun; 56(6):1619-25. PubMed ID: 21523369
[TBL] [Abstract][Full Text] [Related]
2. Lubiprostone: chronic constipation and irritable bowel syndrome with constipation.
Lacy BE; Chey WD
Expert Opin Pharmacother; 2009 Jan; 10(1):143-52. PubMed ID: 19236188
[TBL] [Abstract][Full Text] [Related]
3. Lubiprostone: RU 0211, SPI 0211.
Drugs R D; 2005; 6(4):245-8. PubMed ID: 15991886
[TBL] [Abstract][Full Text] [Related]
4. Lubiprostone for chronic idiopathic constipation and irritable bowel syndrome with constipation.
Saad R; Chey WD
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):497-508. PubMed ID: 19072397
[TBL] [Abstract][Full Text] [Related]
5. Lubiprostone for constipation and irritable bowel syndrome with constipation.
Tuteja AK; Rao SS
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):727-33. PubMed ID: 19090733
[TBL] [Abstract][Full Text] [Related]
6. Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation.
Soubra M; Schey R
Clin Med Insights Gastroenterol; 2012; 5():23-30. PubMed ID: 24833931
[TBL] [Abstract][Full Text] [Related]
7. Lubiprostone: in constipation-predominant irritable bowel syndrome.
Carter NJ; Scott LJ
Drugs; 2009 Jun; 69(9):1229-37. PubMed ID: 19537839
[TBL] [Abstract][Full Text] [Related]
8. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders.
Ginzburg R; Ambizas EM
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1091-7. PubMed ID: 18680443
[TBL] [Abstract][Full Text] [Related]
10. Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.
Chamberlain SM; Rao SS
Expert Opin Drug Saf; 2012 Sep; 11(5):841-50. PubMed ID: 22834474
[TBL] [Abstract][Full Text] [Related]
11. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
Thomas RH; Luthin DR
Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
[TBL] [Abstract][Full Text] [Related]
12. Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.
Owen RT
Drugs Today (Barc); 2008 Sep; 44(9):645-52. PubMed ID: 19137119
[TBL] [Abstract][Full Text] [Related]
13. Lubiprostone: a novel treatment for chronic constipation.
Lacy BE; Levy LC
Clin Interv Aging; 2008; 3(2):357-64. PubMed ID: 18686757
[TBL] [Abstract][Full Text] [Related]
14. Lubiprostone: chloride channel activator for chronic constipation.
Rivkin A; Chagan L
Clin Ther; 2006 Dec; 28(12):2008-21. PubMed ID: 17296458
[TBL] [Abstract][Full Text] [Related]
15. Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.
Med Lett Drugs Ther; 2008 Jul; 50(1290):53-4. PubMed ID: 18617872
[No Abstract] [Full Text] [Related]
16. Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation.
Chey WD; Drossman DA; Johanson JF; Scott C; Panas RM; Ueno R
Aliment Pharmacol Ther; 2012 Mar; 35(5):587-99. PubMed ID: 22251419
[TBL] [Abstract][Full Text] [Related]
17. Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.
Raschi E; De Ponti F
Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):293-305. PubMed ID: 24387275
[TBL] [Abstract][Full Text] [Related]
18. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
[TBL] [Abstract][Full Text] [Related]
19. Novel therapies for constipation.
Thayalasekeran S; Ali H; Tsai HH
World J Gastroenterol; 2013 Dec; 19(45):8247-51. PubMed ID: 24363515
[TBL] [Abstract][Full Text] [Related]
20. Lubiprostone in constipation: clinical evidence and place in therapy.
Wilson N; Schey R
Ther Adv Chronic Dis; 2015 Mar; 6(2):40-50. PubMed ID: 25729555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
